<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jeffers SA</submitter><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>ODCDC CDC HHS</funding><funding>NCI NIH HHS</funding><pagination>15748-53</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC524836</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>101(44)</volume><pubmed_abstract>Angiotensin-converting enzyme 2 (ACE2) is a receptor for SARS-CoV, the novel coronavirus that causes severe acute respiratory syndrome [Li, W. Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) Nature 426, 450-454]. We have identified a different human cellular glycoprotein that can serve as an alternative receptor for SARS-CoV. A human lung cDNA library in vesicular stomatitis virus G pseudotyped retrovirus was transduced into Chinese hamster ovary cells, and the cells were sorted for binding of soluble SARS-CoV spike (S) glycoproteins, S(590) and S(1180). Clones of transduced cells that bound SARS-CoV S glycoprotein were inoculated with SARS-CoV, and increases in subgenomic viral RNA from 1-16</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.</pubmed_title><pmcid>PMC524836</pmcid><funding_grant_id>R01 HL 67671</funding_grant_id><funding_grant_id>N01AI65315</funding_grant_id><funding_grant_id>901 CCU 216988</funding_grant_id><funding_grant_id>N01 AI 25490</funding_grant_id><funding_grant_id>R01 AI025231</funding_grant_id><funding_grant_id>N01 AI 25489</funding_grant_id><funding_grant_id>R01 AI 25231</funding_grant_id><funding_grant_id>T32 AI007537</funding_grant_id><funding_grant_id>N01 AI 65315</funding_grant_id><funding_grant_id>P30 CA046934</funding_grant_id><funding_grant_id>P01 AI 59576</funding_grant_id><funding_grant_id>P01 AI059576</funding_grant_id><funding_grant_id>N01AI25489</funding_grant_id><funding_grant_id>P30 CA 046934</funding_grant_id><funding_grant_id>T32 AI 07537-04</funding_grant_id><funding_grant_id>P01 HL067671</funding_grant_id><funding_grant_id>N01AI25490</funding_grant_id><pubmed_authors>Tusell SM</pubmed_authors><pubmed_authors>Jeffers SA</pubmed_authors><pubmed_authors>Wentworth DE</pubmed_authors><pubmed_authors>Gillim-Ross L</pubmed_authors><pubmed_authors>Achenbach JE</pubmed_authors><pubmed_authors>Thomas WD</pubmed_authors><pubmed_authors>Babcock GJ</pubmed_authors><pubmed_authors>Demartini JC</pubmed_authors><pubmed_authors>Ambrosino DM</pubmed_authors><pubmed_authors>Holmes KV</pubmed_authors><pubmed_authors>Thackray LB</pubmed_authors><pubmed_authors>Mason RJ</pubmed_authors><pubmed_authors>Hemmila EM</pubmed_authors><pubmed_authors>Young MD</pubmed_authors></additional><is_claimable>false</is_claimable><name>CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.</name><description>Angiotensin-converting enzyme 2 (ACE2) is a receptor for SARS-CoV, the novel coronavirus that causes severe acute respiratory syndrome [Li, W. Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) Nature 426, 450-454]. We have identified a different human cellular glycoprotein that can serve as an alternative receptor for SARS-CoV. A human lung cDNA library in vesicular stomatitis virus G pseudotyped retrovirus was transduced into Chinese hamster ovary cells, and the cells were sorted for binding of soluble SARS-CoV spike (S) glycoproteins, S(590) and S(1180). Clones of transduced cells that bound SARS-CoV S glycoprotein were inoculated with SARS-CoV, and increases in subgenomic viral RNA from 1-16</description><dates><release>2004-01-01T00:00:00Z</release><publication>2004 Nov</publication><modification>2025-04-27T00:42:51.814Z</modification><creation>2019-03-27T01:08:18Z</creation></dates><accession>S-EPMC524836</accession><cross_references><pubmed>15496474</pubmed><doi>10.1073/pnas.0403812101</doi></cross_references></HashMap>